702 Prospective, multicenter study of apatinib in treating gynecological cancer patients: A real-world study from China

H Shi; H Cheng; L Wang; Y Wang; Y Jia

doi:10.1136/ijgc-2021-ESGO.278

Article info

PDF

Miscellaneous

702 Prospective, multicenter study of apatinib in treating gynecological cancer patients: A real-world study from China

Free

Authors

H Shi First Affiliated Hospital of Zhengzhou University, Gynecology, Zhengzhou, China PubMed articles Google scholar articles
H Cheng Henan Cancer Hospital, gynaecology, Zhengzhou Shi, China PubMed articles Google scholar articles
L Wang Henan Cancer Hospital, gynaecology, Zhengzhou Shi, China PubMed articles Google scholar articles
Y Wang The Affiliated Renmin Hospital of Zhengzhou University, gynaecology, Zhengzhou Shi, China PubMed articles Google scholar articles
Y Jia First Affiliated Hospital of Zhengzhou University, gynaecology, Zhengzhou Shi, China PubMed articles Google scholar articles

Citation

Shi H, Cheng H, Wang L, et al

702 Prospective, multicenter study of apatinib in treating gynecological cancer patients: A real-world study from China

International Journal of Gynecologic Cancer 2021;31:A166-A167.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password